209 related articles for article (PubMed ID: 11412872)
21. Dystrophin-Deficient Cardiomyopathy.
Kamdar F; Garry DJ
J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
[TBL] [Abstract][Full Text] [Related]
22. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.
Bello L; Campadello P; Barp A; Fanin M; Semplicini C; Sorarù G; Caumo L; Calore C; Angelini C; Pegoraro E
Sci Rep; 2016 Sep; 6():32439. PubMed ID: 27582364
[TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
24. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
[TBL] [Abstract][Full Text] [Related]
25. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
27. Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy.
Shim JY; Kim TS
Yonsei Med J; 2003 Feb; 44(1):15-23. PubMed ID: 12619170
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy.
Yoshida K; Ikeda S; Nakamura A; Kagoshima M; Takeda S; Shoji S; Yanagisawa N
Muscle Nerve; 1993 Nov; 16(11):1161-6. PubMed ID: 8413368
[TBL] [Abstract][Full Text] [Related]
29. Becker muscular dystrophy severity is linked to the structure of dystrophin.
Nicolas A; Raguénès-Nicol C; Ben Yaou R; Ameziane-Le Hir S; Chéron A; Vié V; Claustres M; Leturcq F; Delalande O; Hubert JF; Tuffery-Giraud S; Giudice E; Le Rumeur E;
Hum Mol Genet; 2015 Mar; 24(5):1267-79. PubMed ID: 25348330
[TBL] [Abstract][Full Text] [Related]
30. [Clinical features of patients with Becker muscular dystrophy and deletions of the rod domain of dystrophin gene].
Wang Y; Zhu Y; Yang J; Li Y; Sun J; Zhan Y; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):14-17. PubMed ID: 29419852
[TBL] [Abstract][Full Text] [Related]
31. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript.
Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M
Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544
[TBL] [Abstract][Full Text] [Related]
32. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.
Viggiano E; Ergoli M; Picillo E; Politano L
Hum Genet; 2016 Jul; 135(7):685-98. PubMed ID: 27098336
[TBL] [Abstract][Full Text] [Related]
33. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.
Kaspar RW; Allen HD; Ray WC; Alvarez CE; Kissel JT; Pestronk A; Weiss RB; Flanigan KM; Mendell JR; Montanaro F
Circ Cardiovasc Genet; 2009 Dec; 2(6):544-51. PubMed ID: 20031633
[TBL] [Abstract][Full Text] [Related]
34. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
35. Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.
Lim KRQ; Sheri N; Nguyen Q; Yokota T
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650403
[TBL] [Abstract][Full Text] [Related]
36. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
[TBL] [Abstract][Full Text] [Related]
38. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F
Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249
[TBL] [Abstract][Full Text] [Related]
39. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
Maruyama R; Aoki Y; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
[TBL] [Abstract][Full Text] [Related]
40. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
